drugset / Trial / NCT03702426
Comparison of the Efficacy of Granulocyte-Macrophage Colony Stimulating Factor (GM-CSF) and Norfloxacin in Secondary Prophylaxis for Spontaneous Bacterial Peritonitis
RandomizedParallel-groupDouble-blindTreatment
Summary
-Consecutive patients of decompensated cirrhosis of any etiology, presenting to the Institute of Liver and Biliary Sciences hospital with spontaneous bacterial peritonitis will be evaluated
Timeline
- Start
- 2018-07-23
- Primary completion
- 2019-07-31
- Completion
- 2019-07-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GMCSF | Unknown | 1.5 ug/kg | — |
| Background | Norfloxacin | Small molecule | 400 mg | Oral |